Amalgamated Bank Sells 4,753 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Amalgamated Bank trimmed its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 56,775 shares of the company’s stock after selling 4,753 shares during the period. Amalgamated Bank’s holdings in Acadia Healthcare were worth $4,415,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Vaughan Nelson Investment Management L.P. acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $24,157,000. OFI Invest Asset Management boosted its holdings in Acadia Healthcare by 290.5% during the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock valued at $21,990,000 after acquiring an additional 246,322 shares during the period. Jennison Associates LLC grew its position in shares of Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after purchasing an additional 238,114 shares during the last quarter. California Public Employees Retirement System increased its stake in shares of Acadia Healthcare by 112.6% in the third quarter. California Public Employees Retirement System now owns 368,382 shares of the company’s stock worth $25,901,000 after purchasing an additional 195,130 shares during the period. Finally, Kingdon Capital Management L.L.C. bought a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $12,058,000.

Acadia Healthcare Trading Down 0.5 %

Shares of NASDAQ ACHC opened at $67.43 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. The company has a market cap of $6.26 billion, a PE ratio of -481.61, a P/E/G ratio of 1.96 and a beta of 1.31. The company has a 50-day moving average of $76.02 and a two-hundred day moving average of $77.40. Acadia Healthcare Company, Inc. has a 1-year low of $64.74 and a 1-year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.75 earnings per share. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current fiscal year.

Insider Buying and Selling at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.00% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on ACHC shares. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, May 3rd. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Bank of America cut their price objective on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, Mizuho dropped their price objective on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $88.89.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.